Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma

BACKGROUND: We aimed to screen a specific secretory protein that could serve as blood diagnostic marker for cholangiocarcinoma (CCA). METHODS: Starting with the analysis of gene expression profiles in tumor tissues and matched normal tissues from cases with CCA and hepatocellular carcinoma (HCC), we...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yong, Zheng, Xiaohu, Jiao, Defeng, Chen, Peng, Xu, Yechuan, Wei, Haiming, Qian, Yeben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414306/
https://www.ncbi.nlm.nih.gov/pubmed/30638862
http://dx.doi.org/10.1016/j.ebiom.2018.12.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414306/
https://www.ncbi.nlm.nih.gov/pubmed/30638862
http://dx.doi.org/10.1016/j.ebiom.2018.12.063

Ejemplares similares